Low SATB1-AS1 expression in BLCA, KIRC, LAML, LGG, LUAD, SARC, SKCM and UVM was associated with poor patient prognosis, suggesting that SATB1-AS1 may play a role as an oncogene in tumor progression. The gene discussed is SATB1; the disease is neoplasm.